James R. Engle serves as Executive at Talecris Biotherapeutics Holdings Corp., where they oversee executive responsibilities. Since joining the company, James R. Engle has executed 12 insider transactions totaling $2.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 1, 2011 involved selling 3,655 shares valued at $0.
James R. Engle currently holds 3,655 shares of Talecris Biotherapeutics Holdings Corp. (TLCR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James R. Engle has been a net seller of TLCR stock. They have purchased $0 and sold $2.1M worth of shares.
James R. Engle's most recent insider trade was on Jun 1, 2011, when they sold 3,655 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $26.94 |
| Discretionary |
| Apr 1, 2011 | TLCR | $0 | Award | 1,936 | $N/A | Discretionary |
| Dec 1, 2010 | TLCR | $589.3K | Sale | 27,408 | $21.50 | Discretionary |
| Dec 1, 2010 | TLCR | $38.1K | Option Exercise | 27,408 | $1.39 | Discretionary |
| Nov 1, 2010 | TLCR | $308.4K | Sale | 12,656 | $24.37 | Discretionary |
| Nov 1, 2010 | TLCR | $17.6K | Option Exercise | 12,656 | $1.39 | Discretionary |
| Oct 1, 2010 | TLCR | $842.0K | Sale | 36,912 | $22.81 | Discretionary |
| Oct 1, 2010 | TLCR | $51.3K | Option Exercise | 36,912 | $1.39 | Discretionary |
| Aug 27, 2010 | TLCR | $407.3K | Sale | 18,489 | $22.03 | Discretionary |
| Mar 31, 2010 | TLCR | $54.8K | Payment | 2,751 | $19.92 | Discretionary |
| Sep 30, 2009 | TLCR | $0 | Award | 2,631 | $N/A | Discretionary |